Cited by 109Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and TreatmentsCardiac pacing and defibrillation studies

Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy

Open access
BUNCH, T. JARED, MUNGER, THOMAS M, FRIEDMAN, PAUL A, ASIRVATHAM, SAMUEL J, BRADY, PETER A, CHA, YONG‐MEI, REA, ROBERT F, SHEN, WIN‐KUANG +5 more·2008·Journal of Cardiovascular Electrophysiology

Abstract

Background: Hypertrophic cardiomyopathy (HCM) is often accompanied by atrial fibrillation (AF) due to diastolic dysfunction, elevated left atrial pressure, and enlargement. Although catheter ablation for drug‐refractory AF is an effective treatment, the efficacy in HCM remains to be established. Methods: Thirty‐three consecutive patients (25 male, age 51 ± 11 years) with HCM underwent pulmonary vein (PV) isolation (n = 8) or wide area circumferential ablation with additional linear ablation (n = 25) for drug‐refractory AF. Twelve‐lead and 24‐hour ambulating ECGs, echocardiograms, event monitor strips, and SF 36 quality of life (QOL) surveys were obtained before ablation and for routine follow‐up. Results: Twenty‐one (64%) patients had paroxysmal AF and 12 (36%) had persistent/permanent AF for 6.2 ± 5.2 years. The average ejection fraction was 0.63 ± 0.12. The average left atrial volume index was 70 ± 24 mL/m 2 . Over a follow‐up of 1.5 ± 1.2 years, 1‐year survival with AF elimination was 62%(Confidence Interval [CI]: 66‐84) and with AF control was 75%(CI: 66‐84). AF control was less likely in patients with a persistent/chronic AF, larger left atrial volumes, and more advanced diastolic disease. Additional linear ablation may improve outcomes in patient with severe left atrial enlargement and more advanced diastolic dysfunction. Two patients had a periprocedureal TIA, one PV stenosis, and one died after mitral valve replacement from prosthetic valve thrombosis. QOL scores improved from baseline at 3 and 12 months. Conclusion: Outcomes after AF ablation in patients with HCM are favorable. Diastolic dysfunction, left atrial enlargement, and AF subtype influence outcomes. Future studies of rhythm management approaches in HCM patients are required to clarify the optimal clinical approach.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1540-8167.2008.01192.x

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Callans DJ, Gerstenfeld EP, Dixit S, Lin D, Cooper J, Russo A, Verdino R, Marchlinski FE: Efficacy of pulmonary vein isolation in patients with hypertrophic cardiomyopathy. Circulation 2006;114:704.
  2. Losi MA, Betocchi S, Grimaldi M, Spampinato N, Chiariello M: Het- erogeneity of left ventricular filling dynamics in hypertrophic cardiomy- opathy. Am J Cardiol 1994;73:987-990.

Cited by

Sorted by citations

Authors
BUNCH, T. J., MUNGER, T. M., FRIEDMAN, P. A., ASIRVATHAM, S. J., BRADY, P. A., CHA, Y., REA, R. F., SHEN, W., POWELL, B. D., OMMEN, S. R., MONAHAN, K. H., HAROLDSON, J. M., & PACKER, D. L.
Affiliations
Mayo Clinic (US)
Corresponding author
  • BUNCH, T. JARED
  • PACKER, DOUGLAS L
Venue
Journal of Cardiovascular Electrophysiology
Publisher
Wiley
Published
2008-09-20
Volume
19
Issue
10
Pages
1009-1014
ISSN
  • 1045-3873 (ISSN-L)
  • 1540-8167
OpenAlex
W2011933122
Cited by
109
References
23
Citations by year
2026: 1 · 2025: 4 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 3 · 2019: 1 · 2018: 10 · 2017: 15 · 2016: 8 · 2015: 7 · 2014: 15 · 2013: 9 · 2012: 7
FWCI
4.61
Type
journal article
Language
en
Open access
Locations
Journal of Cardiovascular Electrophysiology (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Keywords
hypertrophic cardiomyopathy, atrial fibrillation, catheter ablation, pulmonary vein isolation, linear ablation, diastolic dysfunction, left atrial enlargement, persistent atrial fibrillation, quality of life, procedural complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review